Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Report 2021

1 Over the Counter (OTC) Drugs & Dietary Supplements Market Overview

• 1.1 Over the Counter (OTC) Drugs & Dietary Supplements Product Scope
• 1.2 Over the Counter (OTC) Drugs & Dietary Supplements Segment by Type
  • 1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Analgesic & pain relievers
  • 1.2.3 Dermatological products
  • 1.2.4 Cough, cold, and flu products
  • 1.2.5 Vitamin supplements
  • 1.2.6 Mineral Supplements
  • 1.2.7 Ophthalmic Products
• 1.3 Over the Counter (OTC) Drugs & Dietary Supplements Segment by Application
  • 1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Pharmacies
  • 1.3.3 Grocery Stores
  • 1.3.4 Vitamin
  • 1.3.5 Health Food Stores
  • 1.3.6 Online Pharmacies
• 1.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Trends (2016-2027)

2 Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Forecasts by Region

• 2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2016-2021)
• 2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2016-2027)
  • 2.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2016-2027)
  • 2.4.3 China Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2016-2027)
  • 2.4.4 Japan Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2016-2027)
  • 2.4.6 India Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2016-2027)

3 Global Over the Counter (OTC) Drugs & Dietary Supplements Competition Landscape by Players

• 3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Sales (2016-2021)
• 3.2 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2016-2021)
• 3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2020)
• 3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Average Price by Company (2016-2021)
• 3.5 Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type

• 4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Type (2016-2021)
• 4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Type (2022-2027)

5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application

• 5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2016-2021)
• 5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2022-2027)

6 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures

• 6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company
  • 6.1.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company (2016-2021)
  • 6.1.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (2016-2021)
• 6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type
  • 6.2.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2022-2027)
• 6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application
  • 6.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application (2022-2027)

7 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures

• 7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company
  • 7.1.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company (2016-2021)
  • 7.1.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (2016-2021)
• 7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type
  • 7.2.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2022-2027)
• 7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application
  • 7.3.1 Europe 141 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 141 Sales Breakdown by Application (2022-2027)

8 China Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures

• 8.1 China Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company
  • 8.1.1 China Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company (2016-2021)
  • 8.1.2 China Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (2016-2021)
• 8.2 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type
  • 8.2.1 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2022-2027)
• 8.3 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application
  • 8.3.1 China 315 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 315 Sales Breakdown by Application (2022-2027)

9 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures

• 9.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company
  • 9.1.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company (2016-2021)
  • 9.1.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (2016-2021)
• 9.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type
  • 9.2.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2022-2027)
• 9.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures

• 10.1 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company
  • 10.1.1 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (2016-2021)
• 10.2 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type
  • 10.2.1 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application
  • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures

• 11.1 India Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company
  • 11.1.1 India Over the Counter (OTC) Drugs & Dietary Supplements Sales by Company (2016-2021)
  • 11.1.2 India Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (2016-2021)
• 11.2 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type
  • 11.2.1 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Type (2022-2027)
• 11.3 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application
  • 11.3.1 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Over the Counter (OTC) Drugs & Dietary Supplements Business

• 12.1 Pfizer Inc.
  • 12.1.1 Pfizer Inc. Corporation Information
  • 12.1.2 Pfizer Inc. Business Overview
  • 12.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.1.5 Pfizer Inc. Recent Development
• 12.2 Novartis International AG
  • 12.2.1 Novartis International AG Corporation Information
  • 12.2.2 Novartis International AG Business Overview
  • 12.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.2.5 Novartis International AG Recent Development
• 12.3 Roche Holding AG
  • 12.3.1 Roche Holding AG Corporation Information
  • 12.3.2 Roche Holding AG Business Overview
  • 12.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.3.5 Roche Holding AG Recent Development
• 12.4 Merck & Co., Inc.
  • 12.4.1 Merck & Co., Inc. Corporation Information
  • 12.4.2 Merck & Co., Inc. Business Overview
  • 12.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.4.5 Merck & Co., Inc. Recent Development
• 12.5 Sanofi S.A
  • 12.5.1 Sanofi S.A Corporation Information
  • 12.5.2 Sanofi S.A Business Overview
  • 12.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.5.5 Sanofi S.A Recent Development
• 12.6 Johnson & Johnson
  • 12.6.1 Johnson & Johnson Corporation Information
  • 12.6.2 Johnson & Johnson Business Overview
  • 12.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.6.5 Johnson & Johnson Recent Development
• 12.7 Gilead Sciences
  • 12.7.1 Gilead Sciences Corporation Information
  • 12.7.2 Gilead Sciences Business Overview
  • 12.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.7.5 Gilead Sciences Recent Development
• 12.8 GlaxoSmithKline plc.
  • 12.8.1 GlaxoSmithKline plc. Corporation Information
  • 12.8.2 GlaxoSmithKline plc. Business Overview
  • 12.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.8.5 GlaxoSmithKline plc. Recent Development
• 12.9 Bayer Healthcare AG
  • 12.9.1 Bayer Healthcare AG Corporation Information
  • 12.9.2 Bayer Healthcare AG Business Overview
  • 12.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.9.5 Bayer Healthcare AG Recent Development
• 12.10 AstraZeneca plc.
  • 12.10.1 AstraZeneca plc. Corporation Information
  • 12.10.2 AstraZeneca plc. Business Overview
  • 12.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.10.5 AstraZeneca plc. Recent Development
• 12.11 Alacer Corp.
  • 12.11.1 Alacer Corp. Corporation Information
  • 12.11.2 Alacer Corp. Business Overview
  • 12.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.11.5 Alacer Corp. Recent Development
• 12.12 Alcon Inc.
  • 12.12.1 Alcon Inc. Corporation Information
  • 12.12.2 Alcon Inc. Business Overview
  • 12.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.12.5 Alcon Inc. Recent Development
• 12.13 Alfresa Pharma Corporation
  • 12.13.1 Alfresa Pharma Corporation Corporation Information
  • 12.13.2 Alfresa Pharma Corporation Business Overview
  • 12.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.13.5 Alfresa Pharma Corporation Recent Development
• 12.14 Alkalon A/S
  • 12.14.1 Alkalon A/S Corporation Information
  • 12.14.2 Alkalon A/S Business Overview
  • 12.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.14.5 Alkalon A/S Recent Development
• 12.15 Alliance Healthcare
  • 12.15.1 Alliance Healthcare Corporation Information
  • 12.15.2 Alliance Healthcare Business Overview
  • 12.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.15.5 Alliance Healthcare Recent Development
• 12.16 Allergan, Plc.
  • 12.16.1 Allergan, Plc. Corporation Information
  • 12.16.2 Allergan, Plc. Business Overview
  • 12.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.16.5 Allergan, Plc. Recent Development
• 12.17 Reckitt Benckiser Plc.
  • 12.17.1 Reckitt Benckiser Plc. Corporation Information
  • 12.17.2 Reckitt Benckiser Plc. Business Overview
  • 12.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.17.5 Reckitt Benckiser Plc. Recent Development
• 12.18 Bausch & Lomb
  • 12.18.1 Bausch & Lomb Corporation Information
  • 12.18.2 Bausch & Lomb Business Overview
  • 12.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.18.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.18.5 Bausch & Lomb Recent Development
• 12.19 AbbVie Inc.
  • 12.19.1 AbbVie Inc. Corporation Information
  • 12.19.2 AbbVie Inc. Business Overview
  • 12.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.19.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.19.5 AbbVie Inc. Recent Development
• 12.20 The Colgate-Palmolive Company
  • 12.20.1 The Colgate-Palmolive Company Corporation Information
  • 12.20.2 The Colgate-Palmolive Company Business Overview
  • 12.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2016-2021)
  • 12.20.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 12.20.5 The Colgate-Palmolive Company Recent Development

13 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Cost Analysis

• 13.1 Over the Counter (OTC) Drugs & Dietary Supplements Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Over the Counter (OTC) Drugs & Dietary Supplements
• 13.4 Over the Counter (OTC) Drugs & Dietary Supplements Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Over the Counter (OTC) Drugs & Dietary Supplements Distributors List
• 14.3 Over the Counter (OTC) Drugs & Dietary Supplements Customers

15 Market Dynamics

• 15.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
• 15.2 Over the Counter (OTC) Drugs & Dietary Supplements Drivers
• 15.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
• 15.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List